
Allegro’s hydrocelin treatment for osteoarthritis has demonstrated a satisfactory safety profile, giving it potential to become a leading disease-modifying treatment …

Allegro has announced that hydrocelin, its injectable microparticle hydrogel, showed no signs of toxicity in two preclinical studies. Allegro is …
Trio become latest Symbiosis commercial additions
UK immunoglobulin supply faces growing pressure, report warns
How will biomarker-led diagnostics reshape respiratory medicine?

